COGT
Cogent Biosciences Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$34.00
-1.33 ▼ -3.76%
🌙 3월 13일 6:39 PM ET (한국 3/14 07:39)
$34.00
+0.00 +0.00%
| Index | RUT | P/E | - | EPS (ttm) | -2.56 | Insider Own | 16.64% | Shs Outstand | 0.16B | Perf Week | -8.31% |
| Market Cap | 5.52B | Forward P/E | - | EPS next Y | 68.91% | Insider Trans | -12.38% | Shs Float | 0.14B | Perf Month | -8.6% |
| Enterprise Value | 4.95B | PEG | - | EPS next Q | -0.52 | Inst Own | 91.35% | Short Float | 11.9% | Perf Quarter | -13.2% |
| Income | -0.33B | P/S | - | EPS this Y | 4.57% | Inst Trans | 8.29% | Short Ratio | 7.71 | Perf Half Y | 165.42% |
| Sales | 0.00B | P/B | 10.01 | EPS next 5Y | - | ROA | -51.99% | Short Interest | 16.11M | Perf YTD | -4.28% |
| Book/sh | 3.4 | P/C | 6.13 | EPS past 3/5Y | -2.22% 30.89% | ROE | -73.7% | 52W High | -22.25% ($43.73) | Perf Year | 366.39% |
| Cash/sh | 5.55 | P/FCF | - | Sales past 3/5Y | - | ROIC | -37.65% | 52W Low | 813.98% ($3.72) | Perf 3Y | 181.69% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -2.18% | Gross Margin | - | Volatility(W/M) | 5.98% 5.32% | Perf 5Y | 315.65% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 2.01 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 14.23 | EPS Q/Q | -6.11% | Profit Margin | - | RSI (14) | 33.06 | Recom | 1.31 |
| Dividend Gr. 3/5Y | - | Current Ratio | 14.23 | Sales Q/Q | - | SMA20 | -9.27% ($37.47) | Beta | 0.5 | Target Price | $53.58 |
| Payout | - | Debt/Eq | 0.38 | Earnings | 2000000 | SMA50 | -8.64% ($37.22) | Rel Volume | 0.79 | Prev Close | $35.33 |
| Employees | 258 | LT Debt/Eq | 0.37 | EPS/Sales Surpr. | -8.59% - | SMA200 | 49.88% ($22.68) | Avg Volume(3M) | 2.09M | Price | $34 |
| IPO | 2018/3/29 | Option/Short | Yes/Yes | Trades | 15404 | Volume | 1,647,220 | Change | -3.76% |
뉴스 로딩 중...